For example, in Thailand, introduction of generic medications was delayed for 1 year from the time compulsory licenses were approved. 32 The reason for this was that some patent-holding companies ...
About the author: Ellen ‘t Hoen is the director of Medicines Law & Policy , a group of legal and policy experts offering advice to international organizations and governments. She is the founder and ...
Vishwas H Devaiah, associate professor at Jindal Global Law School and executive director of the Centre for Intellectual Property Rights Studies, talks to Managing IP about the continuing evolution of ...
After sparring with GSK’s ViiV Healthcare over the price of its HIV medication dolutegravir, Colombia appears to be taking matters into its own hands. Colombian authorities on Tuesday said they plan ...
India's decision in March to grant its first-ever compulsory license, which allows a company to make and market a drug that the patent holder has not been able to make sufficiently affordable and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results